These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14566181)

  • 21. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
    Zhou ZR; Shen TZ; Chen XR; Peng WJ
    Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of perfusion MRI by flow-sensitive alternating inversion recovery and dynamic susceptibility contrast in rats with permanent middle cerebral artery occlusion.
    Hofmeijer J; Schepers J; van der Worp HB; Kappelle LJ; Nicolay K
    NMR Biomed; 2005 Oct; 18(6):390-4. PubMed ID: 16075409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal evolution of MR perfusion in neonatal hypoxic-ischemic encephalopathy.
    Wintermark P; Moessinger AC; Gudinchet F; Meuli R
    J Magn Reson Imaging; 2008 Jun; 27(6):1229-34. PubMed ID: 18504740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases.
    Lee MC; Cha S; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2005 Jun; 21(6):683-93. PubMed ID: 15906330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with contrast-enhanced MR imaging in the follow-up of immunogene-treated glioblastoma multiforme.
    Stenberg L; Englund E; Wirestam R; Siesjö P; Salford LG; Larsson EM
    Acta Radiol; 2006 Oct; 47(8):852-61. PubMed ID: 17050367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dynamic susceptibility contrast MRI with echo planar imaging using 1.0T system: comparison of different EPI sequences].
    Tsuchida C; Yamada H; Kumada H; Maeda M; Koshimoto Y; Kimura H; Kawamura Y; Okamoto J; Takizawa O; Ishii Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Nov; 57(13):860-3. PubMed ID: 9423314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pASL versus DSC perfusion MRI in lateralizing temporal lobe epilepsy.
    Oner AY; Eryurt B; Ucar M; Capraz I; Kurt G; Bilir E; Tali T
    Acta Radiol; 2015 Apr; 56(4):477-81. PubMed ID: 24782571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
    Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
    Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas.
    Lee MC; Cha S; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discrepancy between the dynamic computed tomography and T2 magnetic resonance perfusion imaging in brain tumors: a report of 2 cases.
    Li YD; Geng DY; Zhang QB; Jiang SH
    J Comput Assist Tomogr; 2007; 31(6):896-900. PubMed ID: 18043353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
    Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
    Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method for improving the accuracy of quantitative cerebral perfusion imaging.
    Sakaie KE; Shin W; Curtin KR; McCarthy RM; Cashen TA; Carroll TJ
    J Magn Reson Imaging; 2005 May; 21(5):512-9. PubMed ID: 15834910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
    Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
    J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
    Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [MR-based methods of the functional imaging of the central nervous system].
    Giesel FL; Wüstenberg T; Bongers A; Weber MA; Zechmann C; Baudendistel KT; von Tengg-Kobligk H; Hahn HK; Essig M; Kauczor HU
    Rofo; 2005 May; 177(5):714-30. PubMed ID: 15871087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.